A role for proliferative measurements in clinical oncology?
I feel a simple but properly determined proliferative measurement is within our grasp for clinical use. In addition, multi-parametric flow cytometry offers a means of obtaining more detailed cell kinetic information, using DNA staining combined with staining with one or more antibodies directed against either BrdUrd or proliferation-related proteins.